Login / Signup

Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.

Martin ReinckeAdriana AlbaniGuillaume AssieIrina BancosThierry BrueMichael BuchfelderOlivier ChabreFilippo CeccatoAndrea DanieleMario DetomasGuido Di DalmaziAtanaska ElenkovaJames FindlingAshley B GrossmanCelso E Gomez-SanchezAnthony P HeaneyJuergen HoneggerNiki KaravitakiAndré LacroixEdward R LawsMarco LosaMasanori MurakamiJohn Newell-PriceFrancesca Pecori GiraldiLuis G Pérez-RivasRosario PivonelloWilliam E RaineySilviu SbieraJochen SchopohlConstantine A StratakisMarily TheodoropoulouElisabeth F C van RossumElena ValassiSabina ZacharievaGerman RubinsteinKatrin Ritzel
Published in: European journal of endocrinology (2021)
We endorse the definition of CTP-BADX/NS as radiological progression or new detection of a pituitary tumor on thin-section MRI. We recommend surveillance by MRI after 3 months and every 12 months for the first 3 years after BADX. Subsequently, we suggest clinical evaluation every 12 months and MRI at increasing intervals every 2-4 years (depending on ACTH and clinical parameters). We recommend pituitary surgery as first-line therapy in patients with CTP-BADX/NS. Surgery should be performed before extrasellar expansion of the tumor to obtain complete and long-term remission. Conventional radiotherapy or stereotactic radiosurgery should be utilized as second-line treatment for remnant tumor tissue showing extrasellar extension.
Keyphrases